Increased incidence or recurrence of hepatocellular carcinoma in hepatitis C virus cirrhotic patients treated with direct-acting antivirals: myth or fact?

Expert Rev Anticancer Ther. 2018 Apr;18(4):307-309. doi: 10.1080/14737140.2018.1443814. Epub 2018 Feb 27.

Authors

Marcello Maida¹, Giuseppe Cabibbo², Calogero Cammà²

Affiliations

¹ a Section of Gastroenterology , S. Elia - M. Raimondi Hospital , Caltanissetta , Italy.
² b Section of Gastroenterology , DIBIMIS, University of Palermo , Palermo , Italy.

PMID: 29466888
DOI: 10.1080/14737140.2018.1443814

No abstract available

Keywords: DAAs; HCC; Hepatocellular carcinoma; occurrence; recurrence.

Publication types

Editorial

MeSH terms

Antiviral Agents / administration & dosage*
Carcinoma, Hepatocellular / epidemiology*
Carcinoma, Hepatocellular / etiology
Hepatitis C / complications
Hepatitis C / drug therapy*
Humans
Incidence
Liver Cirrhosis / drug therapy
Liver Neoplasms / epidemiology*
Liver Neoplasms / etiology
Neoplasm Recurrence, Local
Risk Factors
Treatment Outcome

Substances

Antiviral Agents